We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

ORI:NYSEOld Republic International Corporation Analysis

Data as of 2026-04-22 - not real-time

$42.12

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Old Republic International (ORI) trades around $42, well below its DCF fair value of roughly $100, implying a substantial upside. The stock’s forward P/E of about 12 is markedly lower than the industry average of 17.6, and the current dividend yield of 2.94% with a modest 31% payout ratio suggests the dividend is sustainable. Revenue is expanding at a healthy 19.3% annual rate and operating margins remain solid, while the balance sheet shows a manageable debt‑to‑equity of ~30% and a low beta (≈0.12) indicating limited market volatility. Technicals are mixed: the 20‑day SMA sits just below price, the MACD is bullish, and RSI is neutral at 58, but the broader trend is flagged as bearish with decreasing volume and a support around $39.2. Upcoming earnings on April 23 will be a key catalyst, and the “Extreme Greed” sentiment in the Fear & Greed Index adds a contrarian tilt to the valuation case. Overall, the combination of deep undervaluation, solid fundamentals, and attractive dividend makes ORI a compelling buy for investors seeking value with defensive characteristics.
Investors should monitor the earnings release for any guidance shifts, watch the price respect the $39.2 support level, and consider the stock’s low volatility and defensive insurance exposure as a hedge against broader market swings.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Upcoming Q1 earnings release on April 23
  • Bullish MACD histogram and neutral RSI
  • Price near support level with upside potential

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Significant valuation gap to DCF fair value
  • Strong revenue growth and stable operating margins
  • Attractive dividend yield with low payout ratio

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Defensive insurance business with consistent cash flow
  • Low beta and low volatility profile
  • Sustainable dividend and long‑term value upside

Key Metrics & Analysis

Financial Health

Revenue Growth19.30%
Profit Margin10.24%
P/E Ratio11.3
ROE16.31%
ROA2.72%
Debt/Equity30.07
P/B Ratio1.7
Op. Cash Flow$1.2B
Free Cash Flow$-9261325312
Industry P/E17.6

Technical Analysis

TrendBearish
RSI58.6
Support$39.21
Resistance$43.10
MA 20$40.94
MA 50$41.07
MA 200$41.11
MACDBullish
VolumeDecreasing
Fear & Greed Index87.09

Valuation

Fair Value$100.19
Target Price$42.50
Upside/Downside0.91%
GradeUndervalued
TypeBlend
Dividend Yield2.94%

Risk Assessment

Beta0.12
Volatility22.20%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.